BIPOLAR DISORDER: WHY LITHIUM IS STILL FIRST CHOICE
Journal Abstracts Nervenarzt. 2014 Sep;85(9):1166-70. doi: 10.1007/s00115-014-4083-x. [New facts of long-term prophylaxis for bipolar affective disorder]. [Article in German] Bschor T1, Müller-Oerlinghausen B, Stoppe G, Hiemke C. ..
- Posted by Alan Eppel
- Posted in Review Articles
ANTIDEPRESSANTS ARE COUNTERPRODUCTIVE IN BIPOLAR DISORDER
ALAN EPPEL For decades, one of the most controversial issues within psychiatry has being whether or not antidepressants have any role to play in the treatment of bipolar disorder. Bipolar disorder consists of periods of depression and periods ..
- Posted by Alan Eppel
- Posted in Review Articles
The 2016 CANMAT Depression Guidelines: Redefining Levels of Evidence and Levels of Funding
VOL 2 #7 Natasha Snelgrove MD, FRCPC To much fanfare, and with an entire volume of the Canadian Journal of Psychiatry dedicated to these guidelines, the fourth iteration of the Canadian Network of Mood and Anxiety Treatment (CANMAT) Guideli..
- Posted by Editor JPR
- Posted in Editorials & Commentary
Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for Mood disorders: A Review.
Vol 2 #9 Alan Eppel MB, FRCPC The strength of these guidelines released in 2015, is their easy readability and fluent written style coupled with numerous helpful tables and diagrams illustrating key processes. The guidelines were develo..
- Posted by Editor JPR
- Posted in Brief Review,Editorials & Commentary
What Is The Best First Line Antidepressant?
Vol 6 # 1 Alan Eppel Many SSRIs and SNRIs are considered effective as first line choices for the treatment of Major Depression. However the short term nature of randomized controlled trials does not allow the identification of th..
- Posted by Alan Eppel
- Posted in Editorials & Commentary,Surveys
Depression, Difficult to Treat Depression and Treatment Resistant Depression: Reasons for Failing to Respond to First-Line Treatment
Journal of Psychiatry Reform vol 9 #15 Alan Eppel, MB, FRCPC1, Ana Hategan, MD, FRCPC2 Author information 1 Professor, Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote School of Medicine, Faculty of Health Sciences..
- Posted by Editor JPR
- Posted in Editorials & Commentary